Shareholders at Acadia Healthcare (NASDAQ: ACHC) approve directors, pay and plans
Rhea-AI Filing Summary
Acadia Healthcare Company, Inc. held its annual meeting of stockholders on May 6, 2026. Stockholders elected three Class III directors—Daniel J. Cancelmi, Michael J. Fucci and Patrice A. Harris, M.D., M.A.—each receiving over 73.5 million votes in favor.
Investors also approved a second amendment to the Amended and Restated Incentive Compensation Plan, with 80,102,444 votes for and 779,641 against. On a non-binding advisory basis, stockholders approved compensation of the Named Executive Officers, with 60,889,503 votes for and 19,942,924 against.
Finally, stockholders ratified Ernst & Young LLP as independent registered public accounting firm for the fiscal year ending December 31, 2026, with 83,941,435 votes for and 1,947,371 against.
Positive
- None.
Negative
- None.
8-K Event Classification
Key Figures
Key Terms
Class III directors financial
Incentive Compensation Plan financial
non-binding advisory basis financial
Named Executive Officers financial
independent registered public accounting firm financial
broker non-votes financial
AI-generated analysis. How Rhea-AI works. Not financial advice.